A U.S. Food and Drug Administration advisory panel will meet in late June to review metal hip implants.
The FDA announced Thursday that an advisory panel will consult doctors, patients and researchers regarding metal-on-metal hip implants.
The panel will meet June 27-28.
Reuters reported the panel will be convened as a result of the August 2010 recall of DePuy ASR hip implants.
The panel will discuss whether or not to recommend that new pre-market testing standards and review requirements be imposed before a medical device can be sold in the U.S.
Reuters reported the FDA meeting will focus on “failure rates, metal ion testing, imaging methods, patient risk factors, follow-up surgery and complications associated with metal-on-metal hip replacement and resurfacing systems.”
Yesterday’s announcement of the upcoming FDA meeting on metal hip implants follows a May 2011 order from the agency requiring medical device manufacturers of metal-on-metal hip implants to collect more safety data.
DePuy’s recall came after data was released that one out of eight patients who received the company’s metal-on-metal ASR hip implant had to have revision surgery. It was estimated that 93,000 people were affected worldwide.
In January, DePuy’s parent company, Johnson and Johnson, said it would take a $3 billion hit to cover the recall.
